DRKS00007934已完成不适用
on-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Europe - ETNA-VTE-Europe
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,809
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Established acute initial or recurrent VTE
- •- Patients treated with edoxaban according to Summary of Product Characteristics (SmPC).
- •- Written informed consent for participation in the study (ICF)
- •- Not simultaneously participating in any interventional study
- •As this is a non-interventional study, no additional selection criteria apply. Patients will only be included in the study after the treating physician has made the clinical decision to prescribe Edoxaban. The prescription behavior will not be influenced.
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
on-interventional study on Edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillatioMedDRA - 10003658: Atrial fibrillationI48Atrial fibrillation and flutterDRKS00007912Daiichi Sankyo Europe GmbH13,980
进行中（未招募）
1 期
A Phase IV study on impact of Edoxaban treatment in Italian cancer patients with venous thromboembolism during antineoplastic therapyVenous thromboembolism event associated with cancerMedDRA version: 21.1Level: LLTClassification code 10066899Term: Venous thromboembolismSystem Organ Class: 100000004866MedDRA version: 21.1Level: PTClassification code 10028997Term: Neoplasm malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003833-14-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA (GOIRC)300
已完成
不适用
Clinical study on the usefullness of edoxaban tosilate hydrate to portal vein thrombosis complicated with chronic liver diseasePortal vein thrombosisJPRN-UMIN000030108Kanazawa University Hospital20
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)Atrial FibrillationNCT03247582Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company234
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)Atrial FibrillationNCT03247569Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company300